Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells
D Belov Kirdajova, J Kriska, J Tureckova… - Frontiers in cellular …, 2020 - frontiersin.org
A plethora of neurological disorders shares a final common deadly pathway known as
excitotoxicity. Among these disorders, ischemic injury is a prominent cause of death and …
excitotoxicity. Among these disorders, ischemic injury is a prominent cause of death and …
The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …
which initiates rapid signal transmission in the synapse before its re-uptake into the …
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Peroxisome proliferator-activated receptor γ (PPARγ) is a widely expressed ligand-
modulated transcription factor that governs the expression of genes involved in …
modulated transcription factor that governs the expression of genes involved in …
Role of excitatory amino acid transporter‐2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics
Glutamate is an essential excitatory neurotransmitter regulating brain functions. Excitatory
amino acid transporter (EAAT)‐2 is one of the major glutamate transporters expressed …
amino acid transporter (EAAT)‐2 is one of the major glutamate transporters expressed …
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
Neuroprotection and brain repair in patients after acute brain damage are still major
unfulfilled medical needs. Pharmacological treatments are either ineffective or confounded …
unfulfilled medical needs. Pharmacological treatments are either ineffective or confounded …
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
AL Sheldon, MB Robinson - Neurochemistry international, 2007 - Elsevier
Extracellular concentrations of the predominant excitatory neurotransmitter, glutamate, and
related excitatory amino acids are maintained at relatively low levels to ensure an …
related excitatory amino acids are maintained at relatively low levels to ensure an …
Excitatory amino acid transporters in physiology and disorders of the central nervous system
AR Malik, TE Willnow - International journal of molecular sciences, 2019 - mdpi.com
Excitatory amino acid transporters (EAATs) encompass a class of five transporters with
distinct expression in neurons and glia of the central nervous system (CNS). EAATs are …
distinct expression in neurons and glia of the central nervous system (CNS). EAATs are …
Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control
NM Rowley, KK Madsen, A Schousboe… - Neurochemistry …, 2012 - Elsevier
The synthesis, release, reuptake, and metabolism of the excitatory and inhibitory
neurotransmitters glutamate and GABA, respectively, are tightly controlled. Given the role …
neurotransmitters glutamate and GABA, respectively, are tightly controlled. Given the role …
Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities
VP Nakka, A Gusain, SL Mehta, R Raghubir - Molecular neurobiology, 2008 - Springer
Cerebral ischemia/reperfusion (I/R) injury triggers multiple and distinct but overlapping cell
signaling pathways, which may lead to cell survival or cell damage. There is overwhelming …
signaling pathways, which may lead to cell survival or cell damage. There is overwhelming …
Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies
AS Hazell - Neurochemistry international, 2007 - Elsevier
Cerebral damage as a consequence of glutamate-mediated excitotoxicity represents a
major consequence of stroke. However, the development of effective clinical treatments for …
major consequence of stroke. However, the development of effective clinical treatments for …